Results for Vascularized Constructs

The laboratory led by Michael Chorny, PhD, designs delivery systems for drugs and biotherapeutics, focusing on vascular proliferative diseases and high-risk malignancies. Biodegradable nanoparticles and prodrugs are optimized to enhance and extend therapeutic activity, and minimize adverse effects.

The work of scientists in the Center for Craniofacial Innovation will have a direct bearing on the discovery of drugs to mitigate malformation phenotypes and functional genomics of human candidate genes implicated in craniofacial disorders.